Resume-aware faculty matching

Find professors who actually fit you

Upload your resume. Four AI agents analyze your background, rank the faculty who fit, inspect their recent research, and help you draft outreach — grounded in their actual work, not templates.

Free to startNo credit cardCancel anytime
Top matches Balanced preset
Dr. Sarah Chen
Stanford · Interpretability · NLP
91
Dr. Marcus Holloway
MIT · Robotics · RL
84
Dr. Aisha Okonkwo
CMU · Fairness · HCI
82
Nova · Professor Researcher · re-ranking top 20…

Noa'a Shimoni

· ProfessorVerified

Rutgers University · Family Medicine

Active 2002–2025

h-index10
Citations380
Papers229 last 5y
Funding
See your match with Noa'a Shimoni — sign in to PhdFit.Sign in

About

Dr. Noa'A Shimoni joined the Department of Family Medicine at Rutgers New Jersey Medical School in 2012 as the Medical Director of Student Health Services. She is an alumna of NJMS and completed her residency at Einstein-Beth Israel Medical Center. Dr. Shimoni completed a Fellowship in Family Planning and earned an MPH in epidemiology at Columbia University. Her research interests center on long acting reversible contraception, and she has authored publications on topics such as intrauterine contraceptives, vaginal contraceptive rings, and predictors of contraceptive compliance. Her clinical expertise includes family medicine and family planning, and she is fluent in Hebrew and Spanish.

Research topics

  • Computer Science
  • Information Retrieval
  • Medicine
  • Mathematics
  • Psychology
  • Data science
  • Statistics
  • Psychiatry
  • Internal medicine
  • Surgery
  • Emergency medicine
  • Biology
  • Environmental health

Selected publications

  • Bloodborne Pathogen Exposure and the Culture of Reporting Sharps Injuries at a Large Academic Institution

    Journal of environmental health · 2025-01-01

    articleOpen accessSenior author

    Our study objectives were to describe injuries from sharps and gain insight into the culture of injury reporting among healthcare professionals at an academic medical center. We performed a retrospective chart review and analyzed sharps injuries reported in 2021 using chi-square analysis for categorical variables and t-tests or analysis of variance (ANOVA) tests for continuous variables. The highest rates of sharps injuries were reported by dental students (6.9%) and resident physicians (3.6%), followed by a smaller percentage of nurses, attending physicians, dental faculty, and medical students ( p < .001). The majority of injuries were reported to occur while administering an injection and/or working in the dental clinics (39%). The median number of days to report an injury was 0 days for dental students, 2 days for resident physicians ( p < .001), and 3 days for medical students ( p = .004). We found that sharps injuries continue to occur in the clinical teaching environment and could reflect procedures that confer a higher risk of injury. Further, our study suggests that there is a stronger culture of reporting among dental students.

  • Telehealth to improve continuity for patients receiving buprenorphine treatment for opioid use disorder

    2022 · 6 citations

    Senior authorCorresponding
    • Medicine
    • Emergency medicine
    • Internal medicine

    Context: Buprenorphine is medication-assisted treatment for opioid use disorder. It is a controlled substance and most states limit the dispensing to a 30-day supply. Patients with opioid use disorder often have social determinants of health barriers that make it difficult to engage with the health system to obtain a new supply of buprenorphine every month. Telehealth can be used to reduce barriers to accessing care and improve continuity of care for patients receiving buprenorphine treatment. Objective: To assess the rates of patient continuity for patients receiving buprenorphine treatment via tele-health versus in-person in a primary care outpatient setting. Study Design: Review of patients receiving buprenorphine treatment for opioid use disorder and rates of continuity by visit type during a 2-year time period May 2019-May 2021. Dataset: EPIC electronic medical records from an urban university-affiliated ambulatory primary care practice in New Jersey. Population Studied: Patients scheduled for a visit in the outpatient primary care clinic. Approximately 69% were African American, 22% Hispanic, and 9% other. The majority were enrolled in Medicaid. 80% of patients faced one or more barriers to social determinants of health including transportation, housing, and economic stability. Intervention: Establishment and implementation of HIPAA compliant tele-health following approved state guidelines for buprenorphine prescribing via tele-health. Appointments were scheduled in-person or tele-health by patients' preference. Outcome Measures: Rates of continuity by visit type for patients receiving buprenorphine treatment during the study time period compared by chi-square. Results: Of the 487 patients seen via tele-health, 297 (61%) continued to receive follow up care. Of the 811 patients seen in-person, 400 (49.3%) continued to receive follow up care, p<.0001. The patients who did not continue to receive follow up care were lost to follow up despite attempts to reach patients to re-engage in care. Conclusions: Our study shows that rates of continuity of care are higher using tele-health for patients receiving medication assisted therapy for opioid use disorder. In an urban underserved population, tele-health can result in improved continuity of care for patients with opioid use disorder. Telehealth may reduce barriers to accessing care including transportation, work schedule, childcare, and other competing demands.

  • A Pilot Study to Understand the Adolescent Pain Experience During Contraceptive Implant Insertion

    Journal of Pediatric and Adolescent Gynecology · 2021-01-27 · 3 citations

    articleSenior author
  • Best practices for collecting repeated measures data using text messages

    BMC Medical Research Methodology · 2020 · 11 citations

    1st authorCorresponding
    • Computer Science
    • Information Retrieval
    • Computer Science

    BACKGROUND: Researchers and clinicians use text messages to collect data with the advantage of real time capture when compared with standard data collection methods. This article reviews project setup and management for successfully collecting patient-reported data through text messages. METHODS: We review our experience enrolling over 2600 participants in six clinical trials that used text messages to relay information or collect data. We also reviewed the literature on text messages used for repeated data collection. We classify recommendations according to common themes: the text message, the data submitted and the phone used. RESULTS: We present lessons learned and discuss how to create text message content, select a data collection platform with practical features, manage the data thoughtfully and consistently, and work with patients, participants and their phones to protect privacy. Researchers and clinicians should design text messages to include short, simple prompts and answer choices. They should decide whether and when to send reminders if participants do not respond and set parameters regarding when and how often to contact patients for missing data. Data collection platforms send, receive, and store messages. They can validate responses and send error messages. Researchers should develop a protocol to append and correct data in order to improve consistency with data handling. At the time of enrollment, researchers should ensure that participants can receive and respond to messages. Researchers should address privacy concerns and plan for service interruptions by obtaining alternate participant contact information and providing participants with a backup data collection method. CONCLUSIONS: Careful planning and execution can reward clinicians and investigators with complete, timely and accurate data sets.

  • Intrauterine Contraception

    2020-01-01 · 1 citations

    book-chapter1st authorCorresponding
  • 208. Evaluation of Pre-Procedural Anxiety and Procedural Pain During Contraceptive Implant Insertion - A Pilot Study

    Journal of Adolescent Health · 2020

    • Medicine
    • Psychiatry
    • Surgery
  • Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing

    Contraception · 2019-03-01 · 8 citations

    article1st authorCorresponding
  • Can ultrasound predict IUD expulsion after medical abortion?

    Contraception · 2014-01-18 · 21 citations

    article1st authorCorresponding
  • Predictors of noncompliance in an oral contraceptive clinical trial

    Contraception · 2011-11-14 · 69 citations

    article
  • Timing of Copper Intrauterine Device Insertion After Medical Abortion

    Obstetrics and Gynecology · 2011-09-01 · 55 citations

    article1st authorCorresponding

    OBJECTIVE: To compare intrauterine device (IUD) use at 6 months in women randomized to receive an intrauterine copper contraceptive 1 week compared with 1 month after medical abortion. METHODS: We recruited women undergoing medical abortion with mifepristone and misoprostol and choosing the copper IUD for contraception. We randomly assigned participants to "immediate" insertion 1 week after mifepristone or "delayed" insertion 4-6 weeks later. We followed rates of IUD insertion, 6-month utilization, expulsion, removal, and pregnancy. Participants recorded bleeding in a diary for 4 weeks. RESULTS: We randomized 156 participants. We inserted an IUD in 97% of participants in the immediate group and 76% in the delayed group (P<.001). At 6 months, 69% of participants in the immediate group used the IUD compared with 60% in the delayed group (P=.24). Expulsion rates were comparable; 12% (8 of 69) in the immediate group compared with 11% (7 of 65) in the delayed group. Removals occurred in 14% (10 of 69) of immediate and 8% (5 of 65) of delayed group participants (P=.21). Four pregnancies occurred in delayed group participants who did not return for IUD insertion (P=.09). The immediate and delayed groups reported a median of 20 and 19 bleeding or spotting days, respectively (P=.15). We detected no cases of serious infection, uterine perforation, or hemorrhage. CONCLUSION: Immediate insertion increased uptake of the IUD without increasing expulsions or bleeding. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, www.clinialtrials.gov, . LEVEL OF EVIDENCE: I.

Frequent coauthors

  • Carolyn Westhoff

    Columbia University Irving Medical Center

    19 shared
  • Kristyn Brandi

    University of California, San Francisco

    8 shared
  • Sari Bentsianov

    Rutgers, The State University of New Jersey

    8 shared
  • Anne Davis

    7 shared
  • María Elena Ramos

    5 shared
  • Ping-Hsin Chen

    Rutgers New Jersey Medical School

    4 shared
  • Michelle J. Frondelli

    Rutgers, The State University of New Jersey

    4 shared
  • Tasmiah Choudhury

    Rutgers New Jersey Medical School

    4 shared

Education

  • M.D.

    UMDNJ-NJMS

    2004
  • B.A.

    Rutgers University

    1995
  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Noa'a Shimoni

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup